Scotland’s National Health Service has stopped all new prescriptions of puberty-blocking drugs and other hormone treatments for minors, citing a sweeping review of youth gender services released in England last week.
It is the sixth country in Europe to limit such treatments, and its changes are among the most restrictive.
England and carried out by Dr. Hilary Cass, an independent pediatrician, over the course of four years, concluded that the evidence for benefits of youth gender treatments was “remarkably weak” and that pressing questions remained about potential long-term risks.
This month, following recommendations by Dr. Cass, N.H.S.
Hormone therapies, including estrogen and testosterone, are still available to teenagers in England aged 16 and up.
Persons:
Hilary Cass, . Cass
Organizations:
Health Service, N.H.S
Locations:
England, Europe, N.H.S